**
Epilepsy patients across the UK are grappling with alarming disruptions in their medication supply, raising fears of life-threatening seizures. With approximately 630,000 individuals living with epilepsy in the UK, the inability to access essential medications is not just inconvenient; it poses severe health risks. Calls for government intervention are intensifying, as charities demand the establishment of more resilient supply chains to safeguard patient health amidst growing global uncertainties.
The Impact of Supply Shortages
Recent reports indicate that numerous medications, including those crucial for managing epilepsy, are becoming increasingly difficult to obtain. Beth Baker-Carey, a 28-year-old from Doncaster, shared her distressing experience of being unable to secure her medication, which she has relied on since the age of two to control her seizures. “It’s really scary to think that through no fault of my own, this could be the reason I don’t wake up in the morning,” she expressed, highlighting the precarious nature of her condition.
The situation has worsened particularly since the onset of the conflict in Iran, although the Department of Health and Social Care (DHSC) has stated that these shortages are not directly linked to the geopolitical unrest. Nevertheless, Baker-Carey has faced repeated notifications from pharmacies regarding stock shortages, forcing her to navigate multiple locations in search of her life-sustaining medication. “I’ve had to jump through hoops and go to different pharmacies to get medication,” she lamented, stressing the anxiety that accompanies such uncertainty.
The Role of Stress in Seizure Management
Chloe Christoforou, another epilepsy patient, echoed similar concerns, revealing that the stress associated with obtaining her medication has directly impacted her health. Since the beginning of the conflict, she has experienced a significant increase in seizure frequency — from three per week to three per day. “It’s scary that I could potentially just drop down and die from sudden, unexpected death in epilepsy,” she warned, underscoring the dire consequences of disrupted medication adherence.
Experts agree that maintaining a consistent medication regimen is crucial for individuals with epilepsy. Pharmacist Thorrun Govind noted, “Disruption can understandably cause concern and, in some cases, clinical risk.” This sentiment is shared by many in the medical community, who recognise that the psychological burden of securing medications can exacerbate the very conditions they aim to treat.
Contributing Factors to Medicine Shortages
The underlying causes of these supply issues are multifaceted. Rising global prices for pharmaceuticals have led to an unsustainable situation in which pharmacies may dispense medications at a loss. The Independent Pharmacies Association’s chief executive, Dr Leyla Hannbeck, pointed out that a significant portion of pharmaceuticals relies on petroleum-derived inputs. Disruptions in key shipping routes, particularly in the Strait of Hormuz, have led to fears of worsening shortages for various essential medicines, including those used for epilepsy, blood pressure, and cancer treatment.
As the situation continues to evolve, drugmakers’ trade body Medicines UK has indicated that shortages may escalate if geopolitical tensions do not subside. “In recent months, we have already seen a record rise in the price pharmacies have to pay to source prescription-only medicines, leaving many struggling to afford supply,” Dr Hannbeck stated, illuminating the complexities of the current pharmaceutical landscape.
Calls for Government Action
In light of these challenges, the Epilepsy Society is urging the government to implement robust measures that ensure the continuity of medication supply chains. Chief executive Clare Pelham emphasised the need for action, stating, “Epilepsy is a cliff-edge condition. Missing even a single dose can have life-threatening consequences.” The society’s call for a secure and resilient supply chain reflects a broader concern for patients with chronic conditions who depend on consistent access to their medications.
While the DHSC has acknowledged the supply issues, they maintain that most medicines remain available and have issued guidance on managing epilepsy patients, including alternative prescriptions from different manufacturers. However, many in the epilepsy community remain sceptical about the adequacy of these measures in safeguarding the health and wellbeing of patients.
Why it Matters
The current crisis in medication supply is more than a logistical issue; it is a public health emergency that threatens the lives of countless individuals reliant on consistent medical treatment. The fears expressed by patients like Baker-Carey and Christoforou highlight the urgent need for government intervention to create a more robust framework for medicine supply chains. As global events continue to create uncertainty, ensuring the availability of life-sustaining medications is not just a matter of convenience—it is a critical component of public health that must be prioritised to protect vulnerable populations.
